Hologic Inc. logo

Hologic Inc. (HOLX)

Market Open
3 Mar, 19:48
NASDAQ (NGS) NASDAQ (NGS)
$
75. 44
-0.01
-0.02%
$
16.82B Market Cap
38.79 P/E Ratio
- Div Yield
0 Volume
3.91 Eps
$ 75.45
Previous Close
Day Range
75.32 75.48
Year Range
51.9 75.49
Want to track HOLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
HOLX earnings report is expected in 57 days (29 Apr 2026)
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock

Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock

Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks | 2 months ago
HOLX vs. LH: Which MedTech Stock Is the Stronger Investment Now?

HOLX vs. LH: Which MedTech Stock Is the Stronger Investment Now?

Labcorp's strategic partnerships, specialty test growth and more attractive valuation tilt the balance as it emerges stronger than Hologic right now.

Zacks | 2 months ago
HOLX's Genius AI Mammography Flags Missed Breast Cancer Cases

HOLX's Genius AI Mammography Flags Missed Breast Cancer Cases

Hologic shares dip as the company unveils new study data showing its Genius AI mammography flags 32% of previously missed breast cancer cases.

Zacks | 2 months ago
Why Hologic (HOLX) is a Top Momentum Stock for the Long-Term

Why Hologic (HOLX) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 2 months ago
Hologic's Genius AI Detection Shows Value by Spotting Missed Cancers

Hologic's Genius AI Detection Shows Value by Spotting Missed Cancers

HOLX's Genius AI Detection flags missed breast cancers, showing promise in improving mammography accuracy and radiologist efficiency.

Zacks | 2 months ago
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know

Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know

Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks | 2 months ago
What Is Driving Hologic's Strength in the US Diagnostics Market?

What Is Driving Hologic's Strength in the US Diagnostics Market?

HOLX's Diagnostics gains accelerate as U.S. molecular testing drives growth and new Panther Fusion and Genius platform approvals widen its runway.

Zacks | 2 months ago
HOLX Stock Up 16% in 6 Months: Is it Still a Hold Heading Into 2026?

HOLX Stock Up 16% in 6 Months: Is it Still a Hold Heading Into 2026?

Hologic shares rise 16% in six months, with divisional strength clinical data and a go-private deal shaping the short-term outlook.

Zacks | 2 months ago
Hologic's BCI Test Shows Growing Impact in Endocrine Therapy Decisions

Hologic's BCI Test Shows Growing Impact in Endocrine Therapy Decisions

HOLX's BCI test gains traction as new SABCS studies are set to highlight its growing role in guiding extended endocrine therapy decisions.

Zacks | 2 months ago
Why Is Hologic (HOLX) Up 1% Since Last Earnings Report?

Why Is Hologic (HOLX) Up 1% Since Last Earnings Report?

Hologic (HOLX) reported earnings 30 days ago. What's next for the stock?

Zacks | 3 months ago
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It

Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It

Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks | 3 months ago
HOLX vs. DGX: Which Healthcare Diagnostics Stock Is the Better Bet?

HOLX vs. DGX: Which Healthcare Diagnostics Stock Is the Better Bet?

DGX's strong YTD gains and momentum in advanced diagnostics and acquisitions highlight why it may stand out in the competitive testing market against HOLX.

Zacks | 3 months ago
Loading...
Load More